company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5946000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5946000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,754000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,979000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4183000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4183000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1520000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2663000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4217000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4217000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3927000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,782000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7340000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7340000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-90000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16021000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16097000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-56000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-70000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-70000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7410000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8012000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8012000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,151000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1389000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9208000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9208000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-66000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6370000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14358000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,33000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7955000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7955000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1253000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29397000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29397000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22328000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1833000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5195000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5195000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3334000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6432000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3049000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3049000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2124000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11233000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11233000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4409000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-954000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7712000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7712000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42683000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2251000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,32000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40404000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40404000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,54196000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,539000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,54735000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,54735000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6619000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,35000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13656000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13656000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,78000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,167000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6434000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1821000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8798000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8798000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4423000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7043000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2618000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2618000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,262000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,262000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,262000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5918000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11038000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11038000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,146000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2261000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2847000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5746000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5746000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-262000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1518000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7550000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5770000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5770000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,174000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,174000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,174000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,198000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,126000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,684000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1848000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3027000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5917000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5917000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3600000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10387000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10387000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,45000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,95000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2171000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-541000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8587000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-66000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11480000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,351000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,351000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,351000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1678000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11940000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11940000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,99000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2316000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-294000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9775000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9775000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35979000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4880000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31117000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31117000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48361000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,245000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48606000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48606000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7714000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15446000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15446000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,152000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2792000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3407000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9039000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9039000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-279000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5045000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7776000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7776000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,250000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,85000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,335000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,335000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-928000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18741000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18741000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,69000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2804000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-55000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15823000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15870000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17301000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17301000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,94929000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,142000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,95071000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,95071000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,96502000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18417000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18417000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,17000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2342000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16077000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16030000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-33000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63930000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19250000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44713000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44713000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,275000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,80000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,355000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,355000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-60388000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,58000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,14000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3038000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1852000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16952000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16952000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21797000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21530000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-312000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-312000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2326000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2326000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2326000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14938000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22061000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22061000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2288000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3075000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16644000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16644000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27883000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34248000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6365000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6365000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,237000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,266000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,266000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10013000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19421000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19421000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-19000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2760000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1656000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18298000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18298000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17581000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31157000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13558000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13558000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4740000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19722000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19722000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2538000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1019000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16123000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16123000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-133000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3008000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21785000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18644000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18644000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2581000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,45000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-71000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1766000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2126000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18232000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18232000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63310000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41210000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41210000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,66816000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,66816000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,66816000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7374000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18339000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18339000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-107000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2223000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1440000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23114000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30938000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7744000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7744000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,71000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,71000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,71000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9802000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16350000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16350000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,47000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-54000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1479000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-213000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15091000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15091000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8679000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22450000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13771000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13771000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2149000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2149000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2149000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,829000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14709000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14709000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-162000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3660000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3222000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7948000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7948000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-102820000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17742000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-85078000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-85078000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5890000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5890000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5890000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-87136000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27869000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27869000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-214000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3874000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2989000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21161000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21181000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48516000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22750000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25766000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25766000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,130862000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1481000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,132343000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,132343000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,85396000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27568000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27568000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-381000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4058000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3668000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20192000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20172000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4439000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33237000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28762000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28762000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2154000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2157000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2157000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10747000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28272000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28272000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-563000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4262000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3734000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20795000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20795000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100020000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36423000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-63683000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-63683000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,240000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,222000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,462000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,462000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-84016000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40912000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40912000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-917000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11131000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3828000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34482000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34482000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-127458000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,92250000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-35208000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-35208000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,107883000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3718000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,111601000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,111601000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,41911000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45695000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45695000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1047000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12589000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4370000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38467000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38468000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-69000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-85208000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,79350000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5927000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5927000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,220250000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1632000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,221882000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,221882000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,177487000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54273000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54273000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-854000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15106000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7090000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32875000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32874000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-151000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-245449000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,117534000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-128066000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-128066000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1072000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1072000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1072000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-159868000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72376000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72376000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,93000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-603000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16711000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14273000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41902000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41902000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1332000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72113000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,66506000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6939000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6939000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,372000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3101000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3473000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3473000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-45368000.0
